Basis for Neulasta® (Pegfilgrastim) Approval Amgen Neulasta® Approved 01/31/02 Jeff Summers DBOP OODP CDER Mechanism of Action Both Neulasta® and Neupogen ...

... Code RAC issued a repayment request letter for the difference between the payment amount for the incorrectly coded procedure and the correctly coded procedure Neulasta ...

Neulasta – claims must be submitted in terms of 1 unit per 6 mg. instead of the total number of milligrams. Excessive hydration services.

... debridements Lysis of adhesions Wrong Principal Diagnosis Coagulation Disorders DRGs/MS-DRGs with only one CC or MCC Discharge disposition Units of service Neulasta ...

Leukine ®, Neupogen ®, Neulasta ® anemia: fatigue, shortness of breath; low Hb &/or hematocrit; Aranesp ®, Procrit ® thrombocytopenia ...

G-CSF PEG-filgrastim: patent situation Amgen’s pegylated filgrastim product Neulasta® was launched in 2002. This product has a prolonged half-life and therefore ...

... WBC > 10,800 Differential Dx: Infection, Chronic inflammation, Medications (steroids), Recovery post chemotherapy, WBC growth factors (Neupogen, Leukine, Neulasta) used ...

A provider administered 6mgs of Neulasta to the beneficiary but billed for 6 units of J2505. According to the definition of the code, six units of J2505 would be 36mg of ...

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * Biological Response Modifiers High-technology or biotech drugs filgrastim (Neupogen) pegfilgrastim (Neulasta) erythropoietin(Epogen, Procrit) darbepoetin alfa (Aranesp ...

Ceredase (alglucerase) $537 . 2001 . Rebif (Interferon beta-1a) $493 . 2005 . Neulasta (Pegfilgrastim) $493 . 2015 . Source: ABN AMRO February 2008

... Hematopoietic growth factors and coagulation factors Stimulate production of certain blood cell types and clotting agents Epogen®,Neupoeng®, Benefix®, Neulasta ...

... Short stay admissions Acute Inpatient Rehabilitation (complex) Outpatient Medical necessity (automated) Transfusion codes (automated) Speech therapy (automated) Neulasta ...

Infusion Services; Neulasta (boosts white blood cell counts to reduce chance of infection in patients undergoing chemotherapy)

... is adjusted according to response; should be adjusted with when hematocrit approaches 36%; check HCT 2x/weekly Colony Stimulating Factors Neupogen (filgrastim),Neulasta ...

Received 2 nd cycle Taxotere® q3wk on Sept 13; Receiving Neulasta® dose Day 1 post-Taxotere® Plan for surgery in Nov.

Pegfilgrastim (Neulasta) -7.3% . 2,668,665 -8.2% . 3,786,237 . Epoetin Alfa (Procrit, Epogen) Change YTD Sep 2007 vs YTD Sep 2008 . 2008 Expenditure YTD Sep 2008

G-CSF: Neupogen™ and Neulasta™ GM-CSF: Leukine™ Help prevent infection by boosting leukocyte production. Recombinant erythropoietin (EPO) for anemia (red blood ...

... as only source Erythropoietin (EPO) Epogen from Amgen Granulocyte colony-stimulating factor (G-CSF) filgrastim sold as Neupogen from Amgen; pegfilgrastim sold as Neulasta ...

... patient New to practice Has not been seen in practice for 3 years * RAC Audits – Region A Outpatient Hospital - Physician Technical Component of Radiology Neulasta ...

Pegfiligastrim (Neulasta) for patients with a decreased WBC. These medications may be needed if the patient is receiving antineoplastic agents that suppress the bone ...